You are here » Home » Companies » Company Overview » Dr Lalchandani Labs Ltd

Dr Lalchandani Labs Ltd.

BSE: 541299 Sector: Health care
NSE: N.A. ISIN Code: INE871Z01013
BSE 00:00 | 23 May 41.00 0
(0.00%)
OPEN

42.00

HIGH

42.00

LOW

41.00

NSE 05:30 | 01 Jan Dr Lalchandani Labs Ltd
OPEN 42.00
PREVIOUS CLOSE 41.00
VOLUME 8000
52-Week high 52.50
52-Week low 18.05
P/E 17.60
Mkt Cap.(Rs cr) 18
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 42.00
CLOSE 41.00
VOLUME 8000
52-Week high 52.50
52-Week low 18.05
P/E 17.60
Mkt Cap.(Rs cr) 18
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Dr Lalchandani Labs Ltd. (DRLALCHANDLAB) - Chairman Speech

Company chairman speech

Dear Shareholders

It is my pleasure to welcome you all to the 04th Annual General Meeting of DrLalchandani Labs Limited for the year 2020-2021.

Dr Lalchandani Labs Limited is an NABL accredited lab functional in the area ofpathology radiology hospital lab management doctor consultation corporate healthcheck-ups since inception of our pathology lab as a proprietorship firm in the year 1986and we have been trying to cater our clients with excellent pathology and diagnosticservices. In order to achieve the said goal we arrange various training programs for ourstaff members to equip them with the latest technologies and amendments to cope up withthe changing needs of the market.

We expect Dr Lalchandani Labs Limited to be one of the top listed laboratories offeringpathology and diagnostic services in next 5 years with various labs and diagnostic centersat different regions of the country.

The company has strong belief to fulfill its commitment and make all dedicated as wellas sincere efforts in executing its planning and strategies. Accordingly the companyspreading its wings in almost each and every corner of India by developing requisiteinfrastructure in order to provide desired/ satisfactory services to our valued customers.

The continued growth of the company in this situation of COVID -19 we are always beenproactive in supporting various Government Initiatives and helping communities around usand had successfully obtain the approval from Indian Council of Medical Research [ICMR]for COVID -19 RT-PCR testing.

The growth of the company could not be well accelerated without the help of our lendinginstitutes who have supported in our liquidity requirements at the continuous interval weare generous to have their confidence in our vision and future prospects.

At the end I would also like to place on record my sincere thanks to all ourwell-wishers associates vendors customers employees and members of the Board who havecontributed to the success of your Company. Lastly I would also like to thank all thestakeholders for their loyalty and continuous support in helping us achieve our vision ofbringing quality health care to our society and also look forward to a positiveinteraction with all in the days to come.

Sd/-

Dr Arjan Lalchandani

Chairman & Managing Director

Dr Lalchandani Labs Limited.

.